Catalyst Wire Dossier Catalyst Wire Dossier

NIAID Tick-borne encephalitis vaccine candidate

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NIAID Tick-borne encephalitis vaccine candidate, covering 2018-07-05 to 2018-07-05. Get the full timeline:

Most recent: Clinical Trial Update: Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) [Phase 2]

See pricing